Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

West Pharmaceutical Services Inc. buy KeyCorp

Start price
€373.10
13.02.24 / 50%
Target price
€438.98
13.02.25
Performance (%)
-9.71%
Price
€336.70
26.04.24
Summary
This prediction is currently active. With a performance of -9.71%, the BUY prediction for West Pharmaceutical Services Inc. by KeyCorp is down slightly. Dividends of €0.19 are taken into consideration when calculating the performance. This prediction currently runs until 13.02.25. The prediction end date can be changed by KeyCorp at any time. KeyCorp has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
West Pharmaceutical Services Inc. -3.607% -3.607%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by KeyCorp for this prediction

In the thread West Pharmaceutical Services Inc. diskutieren
Prediction Buy
Perf. (%) -9.71%
Target price 438.980
Change
Ends at 13.02.25

West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at KeyCorp from $440.00 to $470.00. They now have an "overweight" rating on the stock.
Ratings data for WST provided by MarketBeat

Stopped prediction by KeyCorp for West Pharmaceutical Services Inc.

buy
West Pharmaceutical Services Inc.

Start price
Target price
Perf. (%)
€331.80
28.07.23
€349.62
28.07.24
1.65%
26.04.24